Other studies support the beneficial effects of IL-17A reduction in experimental DN in other mice models, as STZ-induced diabetes and autoimmune diabetes in NOD mice (Emamaullee et al., 2009; Kuriya et al., 2013; Kim et al., 2015; Tong et al., 2015). This evidence concerns the gene IL17A and liver dysplastic nodule.